A month of insights: Key takeaways from May’s conferences
June 23, 2025 | Conferences, Innovation, clinical trials, patient engagement
Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, and tech innovation shaping clinical trials.
May is always a whirlwind for our team, packed with opportunities to connect, learn, and share at some of the most impactful clinical trial and patient-focused conferences of the year. It’s a month where big ideas take centre stage; from technological innovation to patient-centric trial design, critical topics that shape the future of healthcare. Below, we’ve captured some highlights from four conferences that left us feeling inspired.
Transforming engagement at the Measuring Patient Engagement Summit, Boston
The Measuring Patient Engagement Summit offered a valuable space to explore how we can reshape engagement in healthcare. A common thread emerged throughout discussions: engagement must be “transformational, not just transactional.”
The summit showcased real-world initiatives driving change, refining trial protocols, and sparking informed conversations between patients and providers. However, true progress involves more than just patients; it calls for improved healthcare professional education, stronger caregiver support, and wider care team collaboration.
Amid the discussions about defining and measuring success, one point stood out: human stories and real-world impact matter just as much as the numbers.
– Scott Palmer, Principal Patient Writer
Championing equity at MAPS 2025 EMEA meeting, London
Patient engagement and health equity were standout themes at MAPS EMEA 2025, signalling a powerful shift in how Medical Affairs drives impact. The event highlighted a shift toward embedding real patient voices early and consistently, moving far beyond tokenism.
A drive for embedding real patient voices early and consistently to shape strategy, foster trust, and improve outcomes underpinned several of the impactful and thought-provoking workshops. As did the challenge to tackle the systemic barriers that create health inequities — it’s time to understand more fully the social determinants at play and design inclusive, community-focused approaches!
The message was clear and loud. We must listen deeply, collaborate widely, and learn continuously. Which, for those of us in patient engagement, is our rallying cry!
– Stacey Davidson, Head of Content and Strategy
Redefining co-creation at Patients as Partners EU, London
This year, Patients as Partners Europe asked not “why” but “how” we can better involve patients.
Conversations went beyond surface-level engagement, urging accountability and deeper co-creation. A key takeaway was this call to action: “Start with a blank sheet of paper and ask, ‘What are we trying to do?’” It’s a challenge to focus on people over processes.
Whether revamping trial designs or embedding patient voices consistently, the underlying theme was clear. Patients are co-owners of this process, not guests. The urgency and honesty shared across the event were compelling calls to transform intent into tangible impact.
– Sonal Patel, Content Director
Innovation and empathy at Global Clinical Trials Connect, London
At the Global Clinical Trials Connect conference, new technologies and an emphasis on participant needs are reshaping trial designs.
Artificial intelligence (AI) was a major focus, revolutionising tasks like site selection, eligibility checks, and recruitment. A statistic shared during the event highlighted the potential impact of AI; 85% of patients invited to trials via their GP agree to share records, drastically reducing pre-screening workloads.
Still, technology isn’t the only key to progress. Empathy remains essential, with innovations like accessible ePRO interfaces and real-time participant feedback breaking barriers and expanding opportunities for patients to access life-changing care. These advancements underscore that impactful trials rely on both innovation and humanity.
– Katie Breen, Senior Patient Writer
May’s conferences were more than learning opportunities; they challenged us to rethink and reshape what’s possible. Across every event, one message was clear and inspiring: listen to patients, collaborate meaningfully, and push healthcare forward with empathy and innovation.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Why faster trials make participant understanding more important than ever
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
It’s time to stop calling adverse events ‘manageable’
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
The value: why localisation pays off across global trials
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
The solution: Good localisation doesn’t feel translated
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Healthcare information is becoming easier to access. Trust isn’t.
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
Where translation falls short in practice
Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.
Where it all began – why we developed The Experience Gap
Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, and driving better recruitment and…